The HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells

The molecular chaperone HSP90 is involved in stabilization and function of multiple client proteins, many of which represent important oncogenic drivers in NSCLC. Utilization of HSP90 inhibitors as radiosensitizing agents is a promising approach. The antitumor activity of ganetespib, HSP90 inhibito...

Full description

Bibliographic Details
Main Authors: Roberto Gomez-Casal, Chitralekha Bhattacharya, Michael W. Epperly, Per H. Basse, Hong Wang, Xinhui Wang, David A. Proia, Joel S. Greenberger, Mark A. Socinski, Vera Levina
Format: Article
Language:English
Published: MDPI AG 2015-05-01
Series:Cancers
Subjects:
Online Access:http://www.mdpi.com/2072-6694/7/2/0814
_version_ 1797709702315900928
author Roberto Gomez-Casal
Chitralekha Bhattacharya
Michael W. Epperly
Per H. Basse
Hong Wang
Xinhui Wang
David A. Proia
Joel S. Greenberger
Mark A. Socinski
Vera Levina
author_facet Roberto Gomez-Casal
Chitralekha Bhattacharya
Michael W. Epperly
Per H. Basse
Hong Wang
Xinhui Wang
David A. Proia
Joel S. Greenberger
Mark A. Socinski
Vera Levina
author_sort Roberto Gomez-Casal
collection DOAJ
description The molecular chaperone HSP90 is involved in stabilization and function of multiple client proteins, many of which represent important oncogenic drivers in NSCLC. Utilization of HSP90 inhibitors as radiosensitizing agents is a promising approach. The antitumor activity of ganetespib, HSP90 inhibitor, was evaluated in human lung adenocarcinoma (AC) cells for its ability to potentiate the effects of IR treatment in both in vitro and in vivo. The cytotoxic effects of ganetespib included; G2/M cell cycle arrest, inhibition of DNA repair, apoptosis induction, and promotion of senescence. All of these antitumor effects were both concentration- and time-dependent. Both pretreatment and post-radiation treatment with ganetespib at low nanomolar concentrations induced radiosensitization in lung AC cells in vitro. Ganetespib may impart radiosensitization through multiple mechanisms: such as down regulation of the PI3K/Akt pathway; diminished DNA repair capacity and promotion of cellular senescence. In vivo, ganetespib reduced growth of T2821 tumor xenografts in mice and sensitized tumors to IR. Tumor irradiation led to dramatic upregulation of β-catenin expression in tumor tissues, an effect that was mitigated in T2821 xenografts when ganetespib was combined with IR treatments. These data highlight the promise of combining ganetespib with IR therapies in the treatment of AC lung tumors.
first_indexed 2024-03-12T06:41:33Z
format Article
id doaj.art-d966e2c353c84e9cabfc54a6cead9e4f
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-12T06:41:33Z
publishDate 2015-05-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-d966e2c353c84e9cabfc54a6cead9e4f2023-09-03T00:59:38ZengMDPI AGCancers2072-66942015-05-017287690710.3390/cancers7020814cancers7020814The HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma CellsRoberto Gomez-Casal0Chitralekha Bhattacharya1Michael W. Epperly2Per H. Basse3Hong Wang4Xinhui Wang5David A. Proia6Joel S. Greenberger7Mark A. Socinski8Vera Levina9The University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USAThe University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USAThe University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USAThe University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USAThe University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USAHarvard Medical School, Harvard University, 25 Shattuck Street, Boston, MA 02115, USASynta Pharmaceuticals Corp., 45 Hartwell Avenue, Lexington, MA 02421, USAThe University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USAThe University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USAThe University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USAThe molecular chaperone HSP90 is involved in stabilization and function of multiple client proteins, many of which represent important oncogenic drivers in NSCLC. Utilization of HSP90 inhibitors as radiosensitizing agents is a promising approach. The antitumor activity of ganetespib, HSP90 inhibitor, was evaluated in human lung adenocarcinoma (AC) cells for its ability to potentiate the effects of IR treatment in both in vitro and in vivo. The cytotoxic effects of ganetespib included; G2/M cell cycle arrest, inhibition of DNA repair, apoptosis induction, and promotion of senescence. All of these antitumor effects were both concentration- and time-dependent. Both pretreatment and post-radiation treatment with ganetespib at low nanomolar concentrations induced radiosensitization in lung AC cells in vitro. Ganetespib may impart radiosensitization through multiple mechanisms: such as down regulation of the PI3K/Akt pathway; diminished DNA repair capacity and promotion of cellular senescence. In vivo, ganetespib reduced growth of T2821 tumor xenografts in mice and sensitized tumors to IR. Tumor irradiation led to dramatic upregulation of β-catenin expression in tumor tissues, an effect that was mitigated in T2821 xenografts when ganetespib was combined with IR treatments. These data highlight the promise of combining ganetespib with IR therapies in the treatment of AC lung tumors.http://www.mdpi.com/2072-6694/7/2/0814HSP90 inhibitor ganetespiblung adenocarcinomaxenografted tumorsionizing radiationsenescenceapoptosiscell cycleDNA repair
spellingShingle Roberto Gomez-Casal
Chitralekha Bhattacharya
Michael W. Epperly
Per H. Basse
Hong Wang
Xinhui Wang
David A. Proia
Joel S. Greenberger
Mark A. Socinski
Vera Levina
The HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells
Cancers
HSP90 inhibitor ganetespib
lung adenocarcinoma
xenografted tumors
ionizing radiation
senescence
apoptosis
cell cycle
DNA repair
title The HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells
title_full The HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells
title_fullStr The HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells
title_full_unstemmed The HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells
title_short The HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells
title_sort hsp90 inhibitor ganetespib radiosensitizes human lung adenocarcinoma cells
topic HSP90 inhibitor ganetespib
lung adenocarcinoma
xenografted tumors
ionizing radiation
senescence
apoptosis
cell cycle
DNA repair
url http://www.mdpi.com/2072-6694/7/2/0814
work_keys_str_mv AT robertogomezcasal thehsp90inhibitorganetespibradiosensitizeshumanlungadenocarcinomacells
AT chitralekhabhattacharya thehsp90inhibitorganetespibradiosensitizeshumanlungadenocarcinomacells
AT michaelwepperly thehsp90inhibitorganetespibradiosensitizeshumanlungadenocarcinomacells
AT perhbasse thehsp90inhibitorganetespibradiosensitizeshumanlungadenocarcinomacells
AT hongwang thehsp90inhibitorganetespibradiosensitizeshumanlungadenocarcinomacells
AT xinhuiwang thehsp90inhibitorganetespibradiosensitizeshumanlungadenocarcinomacells
AT davidaproia thehsp90inhibitorganetespibradiosensitizeshumanlungadenocarcinomacells
AT joelsgreenberger thehsp90inhibitorganetespibradiosensitizeshumanlungadenocarcinomacells
AT markasocinski thehsp90inhibitorganetespibradiosensitizeshumanlungadenocarcinomacells
AT veralevina thehsp90inhibitorganetespibradiosensitizeshumanlungadenocarcinomacells
AT robertogomezcasal hsp90inhibitorganetespibradiosensitizeshumanlungadenocarcinomacells
AT chitralekhabhattacharya hsp90inhibitorganetespibradiosensitizeshumanlungadenocarcinomacells
AT michaelwepperly hsp90inhibitorganetespibradiosensitizeshumanlungadenocarcinomacells
AT perhbasse hsp90inhibitorganetespibradiosensitizeshumanlungadenocarcinomacells
AT hongwang hsp90inhibitorganetespibradiosensitizeshumanlungadenocarcinomacells
AT xinhuiwang hsp90inhibitorganetespibradiosensitizeshumanlungadenocarcinomacells
AT davidaproia hsp90inhibitorganetespibradiosensitizeshumanlungadenocarcinomacells
AT joelsgreenberger hsp90inhibitorganetespibradiosensitizeshumanlungadenocarcinomacells
AT markasocinski hsp90inhibitorganetespibradiosensitizeshumanlungadenocarcinomacells
AT veralevina hsp90inhibitorganetespibradiosensitizeshumanlungadenocarcinomacells